FDA Questions Low-Cost Drug Import Legislation
The bipartisan legislation, called the Pharmaceutical Market Access and Drug Safety Act, has been long in the making in an effort to lower drug costs. It was introduced late Tuesday by Sen. Byron Dorgan, D-N.D., as an amendment to President Obama's health care overhaul.
Yet even before Dorgan submitted the amendment,...
To view the full article, register now.